-Independent, unbiased -Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions, etc.) for a quick overview of treatment options -Succinct, bulleted information on all classes of medication: on-and off-label indications, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more -all you need to know for each class of drug -Potential interactions and side effects summarized in comparison charts -With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek -Clearly written patient information sheets available for download as printable PDF files New in this edition: -Third-generation antipsychotics with major additions and changes -Pharmacogenomics fully revised -ECT thoroughly revised and updated -BLT / rTMS with extended references -Extrapyramidal side effects chart extended -Antidepressants vilazodone and vortioxetine with extended coverage -Updated chart for switching antidepressants -New chart of agents under investigation for treatment of substance use disorders -Approved and off-label indications updated -New unapproved treatments with significant updates, including anti-inflammatories, hormones, and 5-HT3 antagonists, in depression, dementia, schizophrenia, and anxiety disorders -New agents include: TGAs N-arylpiperazine (brexpiprazole, Rexulti) and phenylpiperazine: (cariprazine, Vraylar), hypnotic suvorexant ( 
